Compile Data Set for Download or QSAR
Report error Found 248 of ic50 data for polymerid = 406
TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246811(cis-10-methoxy-11-(3-methoxypropoxy)-3,3-dimethyl-...)
Affinity DataIC50: 1nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246818(Cis-11-isobutoxy-10-methoxy-3,3-dimethyl-7-oxo-1,2...)
Affinity DataIC50: 1nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246819(Cis-11-(cyclopropylmethoxy)-10-methoxy-3,3-dimethy...)
Affinity DataIC50: 1nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246831(Cis-11-((6-hydroxyhexyl)oxy)-10-methoxy-3,3-dimeth...)
Affinity DataIC50: 1nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246850(Cis-10-methoxy-3,3-dimethyl-7-oxo-11-(pyrrolidin-1...)
Affinity DataIC50: 1.60nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246829(Cis-10-methoxy-3,3-dimethyl-11-(3-(methylthio)prop...)
Affinity DataIC50: 2nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246832(Cis-11-((6-((tert-butoxycarbonyl)amino)hexyl)oxy)-...)
Affinity DataIC50: 2nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246835(Cis-10-methoxy-3,3-dimethyl-11-((6-(methylsulfonam...)
Affinity DataIC50: 2nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289745(US10093671, Example 14)
Affinity DataIC50: 2nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289746(US10093671, Example 15)
Affinity DataIC50: 2nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246812(US10053461, 3 | US10053461, 4 | Cis-11-(benzyloxy)...)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246812(US10053461, 3 | US10053461, 4 | Cis-11-(benzyloxy)...)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246817(Cis-10-methoxy-3,3-dimethyl-7-oxo-11-(2,2,2-triflu...)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246823(Cis-11-(3-hydroxy-2,2-dimethylpropoxy)-10-methoxy-...)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246837(cis-13-chloro-12-(3-methoxypropoxy)-2-oxo-2,5a,6,7...)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289734(US10093671, Example 3)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289756(US10093671, Example 25)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289758(US10093671, Example 27)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289767(US10093671, Example 36)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246820(Cis-10-methoxy-11-(2-methoxyethoxy)-3,3-dimethyl-7...)
Affinity DataIC50: 4nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246821(Cis-11-(3-cyanopropoxy)-10-methoxy-3,3-dimethyl-7-...)
Affinity DataIC50: 4nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289757(US10093671, Example 26)
Affinity DataIC50: 4nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289762(US10093671, Example 31)
Affinity DataIC50: 4nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246816(Cis-10,11-dimethoxy-3,3-dimethyl-7-oxo-1,2,3,3a,7,...)
Affinity DataIC50: 5nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246822(Cis-11-(3-hydroxypropoxy)-10-methoxy-3,3-dimethyl-...)
Affinity DataIC50: 5nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289743(US10093671, Example 12)
Affinity DataIC50: 5nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289750(US10093671, Example 19)
Affinity DataIC50: 5nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246824(Cis-10-methoxy-3,3-dimethyl-11-(3-morpholinopropox...)
Affinity DataIC50: 6nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246834(Cis-11-((6-acetamidohexyl)oxy)-10-methoxy-3,3-dime...)
Affinity DataIC50: 6nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289744(US10093671, Example 13)
Affinity DataIC50: 6nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289752(US10093671, Example 21)
Affinity DataIC50: 6nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289738(US10093671, Example 7)
Affinity DataIC50: 9nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289747(US10093671, Example 16)
Affinity DataIC50: 9nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246810(trans-10-methoxy-11-(3-methoxypropoxy)-3,3-dimethy...)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246827(Cis-11-(4-ethoxy-4-oxobutoxy)-10-methoxy-3,3-dimet...)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289733(US10093671, Example 2)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289741(US10093671, Example 10)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289755(US10093671, Example 24)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289759(US10093671, Example 28)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246830(Cis-10-methoxy-3,3-dimethyl-11-(3-(methylsulfonyl)...)
Affinity DataIC50: 17nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289748(US10093671, Example 17)
Affinity DataIC50: 18nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289754(US10093671, Example 23)
Affinity DataIC50: 18nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246849(Cis-10-methoxy-3,3-dimethyl-7-oxo-11-propyl-1,2,3,...)
Affinity DataIC50: 19nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246833(Cis-11-((6-aminohexyl)oxy)-10-methoxy-3,3-dimethyl...)
Affinity DataIC50: 20nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246836(trans-13-chloro-12-(3-methoxypropoxy)-2-oxo-2,5a,6...)
Affinity DataIC50: 20nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246848(Cis-10-methoxy-3,3,11-trimethyl-7-oxo-1,2,3,3a,7,1...)
Affinity DataIC50: 20nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289753(US10093671, Example 22)
Affinity DataIC50: 21nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289766(US10093671, Example 35)
Affinity DataIC50: 22nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289765(US10093671, Example 34)
Affinity DataIC50: 24nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM246826(Cis-10-methoxy-3,3-dimethyl-7-oxo-11-(3-(2-oxopyrr...)
Affinity DataIC50: 25nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 248 total ) | Next | Last >>
Jump to: